Signing of a research collaboration agreement between the Institut Pasteur, AP-HP and Janssen Biotech, Inc.

The three-year collaboration agreement signed on March 31, 2021 between the Institut Pasteur, the Paris Public Hospital Network (AP-HP) and Janssen Biotech, Inc., the R&D partner of Janssen France, one of the pharmaceutical companies in the Johnson & Johnson group, paves the way for an exploration of the signaling pathways involved in chronic inflammatory rheumatic disorders.

Find out more